Cart
sales@molnova.com
D-fructose-1,6-diphosphate
CAS No. 488-69-7
D-fructose-1,6-diphosphate( Diphosphofructose | Esafosfan | FDP )
Catalog No. M18638 CAS No. 488-69-7
Fosfructose (Diphosphofructose;Esafosfan;FDP) is a cytoprotective natural sugar phosphate for the potential treatment of cardiovascular ischemia, sickle cell anemia and asthma.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 45 | In Stock |
|
| 5MG | 58 | In Stock |
|
| 10MG | 105 | In Stock |
|
| 25MG | 190 | In Stock |
|
| 50MG | 260 | In Stock |
|
| 100MG | 390 | In Stock |
|
| 500MG | 888 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameD-fructose-1,6-diphosphate
-
NoteResearch use only, not for human use.
-
Brief DescriptionFosfructose (Diphosphofructose;Esafosfan;FDP) is a cytoprotective natural sugar phosphate for the potential treatment of cardiovascular ischemia, sickle cell anemia and asthma.
-
DescriptionFosfructose (Diphosphofructose;Esafosfan;FDP) is a cytoprotective natural sugar phosphate for the potential treatment of cardiovascular ischemia, sickle cell anemia and asthma. It acts by stimulating anaerobic glycolysis which generates adenosine triphosphate under ischemic conditions.At equivalent molar concentrations, both the salt and free forms of a compound exhibit comparable biological activity. Nevertheless, the salt form (Fosfructose trisodium) usually boasts enhanced water solubility and stability.
-
In Vitro——
-
In Vivo——
-
SynonymsDiphosphofructose | Esafosfan | FDP
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number488-69-7
-
Formula Weight340.12
-
Molecular FormulaC6H14O12P2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC([C@@H]1[C@H]([C@@H](C(O1)(COP(=O)(O)O)O)O)O)OP(=O)(O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
NSC348884
NSC348884 is a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis, inhibits cell proliferation at an IC50 of 1.7-4.0 μM in distinct cancer cell lines.
-
n-acetylciprofloxaci...
n-acetylciprofloxacin is inhibitor of H37Rv.
-
Avatrombopag
Avatrombopag is a new oral thrombopoietin (TPO) receptor agonist activating TPO receptor and increasing megakaryocytic proliferation/differentiation and platelet production.
